SARS-CoV-2 vaccinations do not lead to progression of monoclonal gammopathy of undetermined significance: Results from the population-based iStopMM screening study Meeting Abstract


Authors: Palmason, R.; Eythorsson, E.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Ekberg, S.; Crowther, M.; Reed, E. R.; Oskarsson, J. Þ.; Sigurdardottir, G. A.; Aspelund, T.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; Thorsteinsdottir, I.; Sveinsdottir, S. V.; Olafsson, I.; Thordardottir, A. R.; Jonsson, A.; Indridason, O. S.; Gislason, G.; Olafsson, A.; Sigurdsson, J. K.; Steingrimsdottir, H.; Long, T. E.; Hultcrantz, M.; Durie, B. G. M.; Harding, S.; Landgren, O.; Palsson, R.; Love, T. J.; Kristinsson, S. Y.
Abstract Title: SARS-CoV-2 vaccinations do not lead to progression of monoclonal gammopathy of undetermined significance: Results from the population-based iStopMM screening study
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 261
End Page: 263
Language: English
ACCESSION: WOS:000893223200106
DOI: 10.1182/blood-2022-157138
PROVIDER: wos
PMCID: PMC9665214
Notes: Meeting Abstract -- PMCID added as part of the Springer Public Health Emergency Collection -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors